-
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials2021 The Lancet Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Carsten Denkert, Fenja Seither, Andreas Schneeweiß, Theresa Link, Jens‐Uwe Blohmer, Marianne Just, +28 more
584citations -
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial2022 Journal of Clinical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Sanne A. L. Bartels, Mila Donker, Coralie Poncet, Nicolas Sauvé, Marieke Evelien Straver, Cornelis J.�H. van de Velde, +20 more
392citations -
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age2021 The Lancet Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access cited by 1 patent
Martine J Piccart, Laura van ‘t Veer, Coralie Poncet, Josephine Lopes Cardozo, Suzette Delaloge, Jean‐Yves Pierga, +26 more
376citations -
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)2021 The Lancet Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Laura Biganzoli, Nicolò Matteo Luca Battisti, Hans P. M. W. Wildiers, Amelia McCartney, Giuseppe A. Colloca, Ian H. Kunkler, +12 more
308citations -
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial2020 The Lancet Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Philip M. Poortmans, Caroline G Weltens, Catherine Fortpied, Carine Kirkove, Karine Peignaux-Casasnovas, Volker Budach, +17 more
302citations -
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges2020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Joerg Heil, Henry M. Kuerer, André Pfob, Gaiane Margishvili Rauch, Hans‐Peter Sinn, Michael Golatta, +1 more
236citations -
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer2023 New England Journal of Medicine article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro Alessandro Peccatori, Hatem A. Azim, Marco Angelo Colleoni, +32 more
229citations -
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study2021 Cancers article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Maggie Banys‐Paluchowski, Maria Luisa Gasparri, Jana de Boniface, Oreste Gentilini, Elmar Stickeler, Steffi Hartmann, +23 more
166citations -
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy138citations
-
Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy2020 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access cited by 1 patent
Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, Jenna Wong, Elma Meershoek‐Klein Kranenbarg, +4 more
133citations -
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20212021 Breast Care article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Nina Ditsch, Cornelia Kolberg‐Liedtke, Michael Friedrich, Christian Jackisch, Ute‐Susann Albert, Maggie Banys‐Paluchowski, +40 more
111citations -
Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer2022 JAMA Surgery article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Janine M. Simons, Thiemo J. A. van Nijnatten, Carmen C. van der Pol, P. J. van Diest, Agnes Jager, David V. Klaveren, +16 more
104citations -
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy2022 Zurich Open Repository and Archive (University of Zurich) article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Vincent M. T. de Jong, Yuwei Wang, Natalie D. ter Hoeve, Mark Opdam, Nikolas Stathonikos, Katarzyna Jóźwiak, +25 more
100citations -
Sentinel Lymph Node Methods in Breast Cancer2022 Seminars in Nuclear Medicine article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Francesco Giammarile, Sergi Vidal‐Sicart, Diana Páez, Olivier Pellet, Enrique Estrada-Lobato, Miriam Mikhail-Lette, +6 more
97citations -
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20222022 Breast Care article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Nina Ditsch, Achim Wöcke, Michael Untch, Christian Jackisch, Ute‐Susann Albert, Maggie Banys‐Paluchowski, +40 more
88citations -
The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer2020 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Kiki M. H. Vangangelt, Andrew R. Green, Isabelle M.F. Heemskerk, Danielle B. Cohen, Gabi W. van Pelt, Marcelo Sobral‐Leite, +5 more
72citations -
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20202020 Breast Care article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Nina Ditsch, Michael Untch, Cornelia Kolberg‐Liedtke, Christian Jackisch, David A. Krug, Michael Friedrich, +40 more
61citations -
Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapy2021 Scientific Reports article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Esmee Koedoot, Liesanne Wolters, Marcel Smid, Peter Stoilov, Gerhard A. Burger, Bram Herpers, +5 more
60citations -
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy2021 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro Alessandro Peccatori, Hatem A. Azim, Marco Angelo Colleoni, +26 more
55citations -
Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/109252021 JNCI Journal of the National Cancer Institute article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Philip M. Poortmans, Henk Struikmans, Peter De Brouwer, Caroline G Weltens, Catherine Fortpied, Carine Kirkove, +14 more
51citations -
Standardization of the tumor-stroma ratio scoring method for breast cancer research2022 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Sophie C. Hagenaars, Kiki M. H. Vangangelt, Gabi W. van Pelt, Zsófia Karancsi, Rob A.�E.�M. Tollenaar, Andrew R. Green, +3 more
48citations -
The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer2020 Therapeutic Advances in Medical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Ulrike Anneliese Nitz, Oleg Gluz, Hans Heinrich Kreipe, Matthias Christgen, Sherko Küemmel, Frederick L. Baehner, +16 more
46citations